Results 191 to 200 of about 505,718 (265)

TLR agonists as adjuvants for viral vaccines: mechanisms, applications, and future directions. [PDF]

Front Microbiol
Shao F, Zhu X, Yi M, Gao H, Wu J, Fang R, Xie Y, Han J, Lu H.   +8 more
europepmc   +1 more source

Active LXR signaling, coupled with elevated mitochondrial and glycolytic metabolism contributes to GM-CSF-induced trained immunity. [PDF]

Front Immunol
Liu Y, Hamid A, Hardege H, Zhang Q, Körner H, Leffers M, Gonzalez NA, Liebisch G, Hoering M, Findeisen H, Placek K, Netea MG, Reinecke H, Schwarz D, Sohrabi Y.   +14 more
europepmc   +1 more source

Comment on: A single dose recombinant AAV based CHIKV vaccine elicits robust and durable protective antibody responses in mice. [PDF]

PLoS Negl Trop Dis
Xu S, Li K, Merits A, Dai Z, Luo J, Zhong X, Zhang O, Yang J, Yang X.   +8 more
europepmc   +1 more source

StealthX: A Versatile and Potent Exosome-Based Vaccine Platform for the Next Pandemic. [PDF]

Vaccines (Basel)
Sun M, Elliott K.
europepmc   +1 more source

Sex Differences in Response to Viral Vector Vaccines-Implications for Future Vaccine Design. [PDF]

Immunol Rev
Grewe I, Zoran T, Addo MM.
europepmc   +1 more source